Form 4 for BMRN BIOMARIN PHARMACEUTICAL INC
Accepted 2022-08-09 00:00:00 ET · period of report 2022-08-05 · accession 0001567619-22-015384 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-08-09 | 2022-08-05 | BMRN | Mueller Brian | EVP, CFO | S - Sale+OE | $94.50 | -3,500 | 30.7K | -10% | -$330.8K |
| D | 2022-08-09 | 2022-08-05 | BMRN | Mueller Brian | EVP, CFO | M - OptEx | $67.81 | +3,500 | 34.2K | +11% | +$237.3K |
| D | 2022-08-09 | 2022-08-05 | BMRN | Mueller Brian | EVP, CFO | M - OptEx | $0.00 | -3,500 | 7,261 | -33% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-08-05 | S | D | 3,500 | $94.50 | 30,726 | D | — | — | (F1) Trade made pursuant to a 10b5-1 plan executed on March 14, 2022. |
| 2 | Common | Common Stock | 2022-08-05 | M | A | 3,500 | $67.81 | 34,226 | D | — | — | (F1) Trade made pursuant to a 10b5-1 plan executed on March 14, 2022. |
| 3 | Derivative | Stock Option (Right to buy Common Stock) | 2022-08-05 | M | D | 3,500 | $0.00 | 7,261 | D | $67.81 · 2013-11-15 to 2023-05-14 | 3,500 Common Stock | (F1) Trade made pursuant to a 10b5-1 plan executed on March 14, 2022. (F2) Reflects the number of options outstanding after the transactions from this specific stock option grant. |